Cape Verde vs Israel: The number of people with susceptibility test result for rifampicin
Cape Verde
98
in 2021
Israel
103
in 2021
Cape Verde rank
110th
Israel rank
108th
The number of people with susceptibility test result for rifampicin over time
- Cape Verde
- Israel
How they compare
Israel currently reports 103 against 98 in Cape Verde, a difference of 5.
That makes Israel's figure about 1.1 times Cape Verde's.
Across all 5 years both countries report, Israel has been ahead every year.
Cape Verde ranks 110th and Israel ranks 108th of 155 countries.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cape Verde | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 82.33 | 129.33 | 47 | Israel |
| 2020s | 87.5 | 96 | 8.5 | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cape Verde or Israel?
- Israel, at 103 against 98 in Cape Verde as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cape Verde and Israel?
- 5, with Israel ahead.
- How many years of comparable data are there for Cape Verde and Israel?
- 5 years are reported by both, from 2017 to 2021.
- How do Cape Verde and Israel rank globally for the number of people with susceptibility test result for rifampicin?
- Cape Verde ranks 110th and Israel ranks 108th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.